Skip to the page

Data / Form D filings / FluidForm Bio, Inc.

FluidForm Bio, Inc.: Form D filing

FluidForm Bio, Inc., a biotechnology company in Waltham, MA, filed a Form D with the SEC in 2026. The latest, on August 27, 2026, reports $1.7 million sold of a $3 million offering to 20 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
852 Winter St., Waltham, MA, 02451
Phone
(781) 691-0980
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2062460

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 27, 2026New notice$3,000,000$1,703,371$1,296,62920Jul 16, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Michael GraffeoExecutive Officer, DirectorPresident and Chief Executive Officer
Adam FeinbergExecutive Officer, DirectorChief Technology Officer
Erik WatersExecutive OfficerChief Financial Officer

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Aug 24, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what FluidForm Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.